Search Within

Advanced Practice Providers

  1. "Pediatric Leukemia"
Formats
  1. Meeting Abstract (29)
  2. Journal Article (16)
Groups
  1. Center for Hematologic Malignancies (45)
  2. Pediatric Leukemia (45)
  3. Pediatrics, Department of (44)
  4. Nursing (43)
  5. Survivorship Research (30)
  6. GSK Faculty (25)

More Groups

People
  1. Suzanne Wolden (22)
  2. Kim Kramer (19)
  3. Sofia Haque (17)
  4. Maria Donzelli (16)
  5. Nancy Kernan (15)
  6. Rachel Kobos (14)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2022 (2)
  4. 2021 (1)
  5. 2020 (1)
  6. 2019 (4)

More Years

Publications
  1. Pediatric Blood and Cancer (11)
  2. Neuro-Oncology (9)
  3. Biology of Blood and Marrow Transplantation (7)
  4. Blood (5)
  5. Bone Marrow Transplantation (2)
  6. Cell (1)

More Publications

Publishers
  1. Wiley Periodicals, Inc (11)
  2. Oxford University Press (9)
  3. Elsevier Inc. (8)
  4. American Society of Hematology (5)
  5. American Society of Clinical Oncology (2)
  6. Nature Publishing Group (2)

More Publishers

Results (45)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Morbidity and mortality after treatment of Ewing sarcoma: A single-institution experience
    Journal Article

    Novetsky Friedman, D.; Chastain, K.; Chou, J. F.; Moskowitz, C. S.; Adsuar, R.; Wexler, L. H.; Chou, A. J.; DeRosa, A.; Candela, J.; Magnan, H.; more...
    Pediatric Blood and Cancer (2017)

    Fulltext@MSK | Save
  • A phase II study of radioimmunotherapy with intraventricular 131I-3F8 for medulloblastoma
    Meeting Abstract

    Kramer, K.; Pandit-Taskar, N.; Humm, J.; Zanzonico, P.; Haque, S.; Dunkel, I.; Wolden, S.; Donzelli, M.; Goldman, D.; Lewis, J.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Management of bevacizumab induced colon micro-perforation in a patient with neuroblastoma
    Meeting Abstract

    Glincher, R.; Modak, S.; LaQuaglia, M.; Marrano, M.
    Pediatric Blood and Cancer (2017)

    Fulltext@MSK | Save
  • PET-adapted therapy with brentuximab vedotin and augmented ICE for relapsed/refractory Hodgkin lymphoma - Lack of Improvement with 3 versus 2 cycles of weekly brentuximab vedotin
    Meeting Abstract

    Moskowitz, A. J.; Schòˆder, H.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation for nonmalignant hematologic disorders using chemotherapy-only cytoreductive regimens and T-cell-depleted grafts from human leukocyte antigen-matched or - mismatched donors
    Journal Article

    Mussetti, A.; Kernan, N. A.; Prockop, S. E.; Scaradavou, A.; Lehrman, R.; Ruggiero, J. M.; Curran, K.; Kobos, R.; O'Reilly, R.; Boulad, F.
    Pediatric Hematology and Oncology (2016)

    Fulltext@MSK | Save
  • Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors
    Journal Article

    Praveen, A.; Friedman, D. N.; Sklar, C.; Oeffinger, K.; Castiel, M.; Kearney, J.; Singh, B.; Prockop, S. E.; Kernan, N. A.; Scaradavou, A.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Response to vaccination in childhood cancer survivors
    Meeting Abstract

    Kobos, R.; Egan, G.; Fischer, C.; Dunkel, I.; Khakoo, Y.; Gilheeney, S.; Shukla, N.; Trippett, T.; Steinherz, P.; Kernan, N.
    Pediatric Blood and Cancer (2016)

    Fulltext@MSK | Save
  • T- cell depleted peripheral blood stem cell (TCD-PBSC) transplants secure consistent engraftment with low risk of acute or chronic GVHD and favorable disease free survival (DFS) and overall survival (OS) for pediatric patients (< 21 years) with AML in CR1
    Meeting Abstract

    Kernan, N. A.; Boulad, F.; Prockop, S. E.; Scaradavou, A.; Kobos, R.; Lehrman, R.; Klein, E.; Wolden, S.; Curran, K. J.; Hasan, A. N.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • T-cell depleted peripheral blood stem cell (TCD-PBSC) transplants secure consistent engraftment with low risk of acute or chronic Gvhd and favorable disease free survival (DFS) and overall survival (OS) for pediatric patients (<21 years) with AML in CR1 or CR2 or MDS including tMDS/AML
    Meeting Abstract

    Kernan, N. A.; Boulad, F.; Prockop, S.; Wolden, S.; Scaradavou, A.; Kobos, R.; Lehrman, R.; Klein, E.; Curran, K. J.; Hasan, A. N.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • High disease-free survival (DFS) supports continued investigation of double-unit cord blood transplantation (DCBT) in children with high-risk acute leukemia especially in the setting of single units with low dose and/or a high degree of HLA-mismatch
    Meeting Abstract

    Scaradavou, A.; Lubin, M.; Hilden, P.; Boulad, F.; Curran, K. J.; Kobos, R.; Prockop, S. E.; O'Reilly, R. J.; Tonon, J. A.; Byam, C.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save